Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

SLEEP AID (doxylamine succinate) tablet [United Natural Foods, Inc. dba UNFI]

Updated Date: Mon, 29 Apr 2024 00:00:00 EDT

May 7, 2024 Uncategorized

LEVOCETIRIZINE DIHYDROCHLORIDE tablet, coated [BJWC (Berkley & Jensen / BJ’S) ]

Updated Date: Mon, 29 Apr 2024 00:00:00 EDT

May 7, 2024 Uncategorized

Simulated chemistry: New AI platform designs tomorrow’s cancer drugs

Researchers have developed a new AI tool to that generate new drug candidates for cancer, which could help […]

May 7, 2024 Uncategorized

Judge warns over “dangerously high” hormone dose prescribed to teenager by online gender clinic

The judge who heads the High Court’s family division has warned of the risks of obtaining hormone prescriptions […]

May 4, 2024 Uncategorized

Saying hello to patients: there is no “one size fits all” approach

Launer makes a good point about the benefit of acknowledging patients with a simple “hello.”1There is no doubt […]

May 4, 2024 Uncategorized

US expert panel says breast cancer screening should begin at 40

Women in the US should begin breast cancer screening with mammography at age 40 and be screened every […]

May 4, 2024 Uncategorized

Growth in UK children living in households with food insecurity

In March 2024, the UK’s Department for Work and Pensions (DWP) reported new data on household food insecurity […]

May 3, 2024 Uncategorized

Toxic household exposures in children

What you need to knowPoisoning is the third most common cause of injury related hospital admission in children […]

May 3, 2024 CME

Cambridge researchers develop robotic nerve devices for neurological conditions

Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide

May 3, 2024 nerve monitoring, Neurological disorders, News, peripheral nerves, robotic nerve cuffs, University of Cambridge

International phase 3 clinical trial for new melanoma treatment recruits first patients

The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda

May 3, 2024 INTerpath-001, keytruda, melanoma, Merck & Co, Moderna, mRNA-4157, News, University College London Hospitals NHS Foundation Trust

Posts navigation

Posts pagination

« Previous 1 … 248 249 250 … 1,871 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy